Gynecology

Family Planning & Oncology, Urogynecoloyg & Endoscopy

Friday, July 20, 2012


08:30-10:00
STRESS URINARY INCONTINENCE
Capsule
Urinary incontinence is a common and potentially debilitating problem. Hundreds of surgical procedures have been described, additional procedures continue to evolve, thereby improving efficacy, safety, and cost-effectiveness, while reducing invasiveness and recurrences. The key to an optimal therapeutic outcome is accurate diagnosis and tailor-made,  appropriate intervention that is acceptable to the patient. Are any of the newer procedures emerging as the best?
Chairperson C. Chong Singapore
08:30-09:30
Debate: Should we perform any surgery other than TVT? Are colposuspensions obsolete?
Proposition: TVT revolutionized the field and provide better results than any colposuspension, with fewer complications
H.C. Han, Singapore
Opposition: Colposuspension operations are worth performing on selected cases
T.S. Lo, Taiwan
Discussion
09:30-10:00 Discussant
H.C. Han, Singapore
T.S. Lo, Taiwan
Singapore Expert opinion on overactive bladder (OAB):
1.    Is it essential for management of patients with urinary incontinence?
2.    How to diagnose an overactive bladder?
3.    Overactive bladder: what treatment options?
4.    What is the best medical treatment for overactive bladder?
5.    Botox for overactive bladder – a new lifeline?

10:00-10:20 Coffee break

10:20-11:50
FAMILY PLANING
Capsule
Understanding the risks and benefits of oral contraceptive
Chairpersons D.S. Seidman ,Israel
A.E. Schindler, Gemany
10:20-10:50 Non contraceptive benefits of hormonal contraceptives
A.E. Schindler, Gemany
10:50-11:20 Drospirenone and the risk of VTE
D.S. Seidman Israel
11:20-11:50 Treatment of Pelvic inflammatory disease
W.J. Ledger, USA

11:50-12:10 Poster viewing

12:10-13:40
NEW APPROACHES IN GYNECOLOGICAL ENDOSCOPY
Supported in part by Karl Storz GmbH
Capsule
Delaying childbearing increases the likelihood to encounter uterine fibroids and infertility. When myomectomy is deemed necessary, the surgical procedure may vary with the skill of the surgeon and the instruments used. New technical developments promise to diversify the capabilities while minimizing risks and side effects
ChairpersonsD.S. Seidman, Israel
J. Donnez, Belgium
12:10-12:40 New generation hysteroscopy
R. Campo, Belgium
12:40-13:10 Laparoscopic Myomectomy: How to ensure successful surgery?
J. Donnez, Belgium
13:10-13:40 Tricks and tips in Hysteroscopic myomectomy
R. Campo, Belgium

13:40-14:30 Lunch break

14:30-16:00
CORRECTION OF PELVIC ORGAN PROLAPSE
Capsule
The best method to correct POP remains elusive. POP affects half of parous women and the life time risk for surgery for POP is over 10%. 1 out of 3 women require more than one surgical repair. This fact may reflect the age-dependent progression, but also the wide variety of the surgical techniques used, indicating the lack of consensus with regard to optimal treatment. While good anatomical restoration does not necessarily imply restoration of normal bladder function, bowel and sexual function, the impact of surgery can sometimes be unpredictable and symptoms can worsen or new ones (such as urine leakage) may appear. Awareness of the existence of multiple defects and recurrences in unrepaired compartments has led to wide use of more comprehensive operations. Synthetic meshes and biological grafts in pelvic reconstructive surgery have increased considerably in recent years, with success rates in the 70-100% range. Nonetheless, not even these procedures are not free of adverse effects. Accordingly, the issue of the best solution has remained unsettled
Chairperson H.C. Han, Singapore
14:30-15:30
Debate: "To Mesh or not to Mesh" - that is the question
Proposition: Mesh augmentation of POP reconstruction provides the best solution
C. Chong Singapore
Opposition: Conservative non-Mesh POP reconstruction is the option with a higher success rate and a lower complication rate
L.C. Lee, Singapore
Discussion
15:30-16:00 Discussants
C. Chong, Singapore
L.C. Lee, Singapore
Tricks of the trade: Expert opinion on:
  1. Choosing the appropriate operation for various types of pathology
  2. Is there a place for conservative management in POP?
  3. "My operation is better": Cure vs. complications. Comparison, neck to neck, of needle-guided, mesh vs. single
  4. What to do with mixed incontinence?

16:00-16:30 Coffee break

16:30-18:00
FREE COMMUNICATIONS - GYNECOLOGY
Chairperson
16:30-16:36 Chlorhexidine-alcohol versus povidone-iodine for cleansing in cesarean sections
J. Amer-Alshiek, Israel
16:36-16:42 Total laparoscopic hysterectomy making easy- the technique and tools: A 5-year experience
M. Quayyum, Bangladesh
16:42-16:48 Laparoscopic hysterectomy: Should the cervix be left in situ? A comparison of total and supracervical laparoscopic hysterectomy for benign disease in a collective of 200 patients
D. Bardens, Germany
16:48-16:54 Some cases of death in association with oral contraceptive
S. Galbavý, Slovakia
16:54-17:00 Robotic hysterectomy and fistula repair for uterovesical fistula: Video presentation
S. Gupta, India
17:00-17:06 Safety and efficacy of two newly-developed endometrial ablation procedures using radiofrequency thermocoagulation for the treatment of severe abnormal uterine bleeding
Y. Geping, China
17:06-17:12 Quantitative point of care HCG assay
V. Trieu, USA
17:12-17:18 Observations in early stage endometrial cancers
J. Parija, India
17:18-17:24 Supportive care needs of women diagnosed with gynecologic cancer
M. Fitch , Canada
17:24-17:30 Efficacy of levonorgestrel intrauterine system (Mirena®) for treatment of early endometrial cancer
L. Wong, Australia
17:30-17:36 Let-7B miRNA as a master regulator of gene expression and oncomir in progression and prediction of high-grade serous ovarian carcinoma
V. Kuznetsov, Singapore
17:36-17:42 Effectiveness and safeness of promestriene use in treatment of vulvovaginal atrophy
G. Grazziotin, Brazil
17:42-17:48 Targeted sphingolipidomics reveal dysregulated glucosylceramide levels in endometriosis
Y.H. Lee, Singapore
17:48-17:54 Molecular cues to polycystic ovary syndrome: lesson from hyperhomocysteinemic rat model
S. Kabir, India

Saturday, July 21, 2012


08:30-10:00
ENDOMETRIOSIS
Capsule
No simple method is available for diagnosis of endometriosis! Poor correlation involving visible implants, symptoms and treatment creates a constant need for new research and refinement of our methods and diagnosis and therapy. Deep endometriosis deserves special attention and thorough understanding as special types of endometriosis
Chairperson R. Campo, Belgium
08:30-09:15
Debate: Is resection of deep-infiltrating endometriosis required prior to IVF?
No: S. Daya Canada
Yes: J. Donnez, Belgium
Discussion
09:15-09:40 Alternatives in medical treatment of endometriosis
B. Chern, Singapore
09:40-10:00 Hormonal contraceptives and endometriosis
A.E. Schindler, Germany 
Objectives Upon completion of this session, the audience will have learned:
  • What to do with endometriosis prior to IVF
  • Unmet need in diagnosis tools for endometriosis
  • Medical and non-medical treatments

10:00-10:20 Coffee break

10:20-11:50
GYNECOLOGICAL ONCOLOGY
Capsule
The relevance of the sentinel lymph node is now being revealed in all types of gynecological oncology, robotic surgery and innovative chemotherapy, expanding the therapeutic choices
Chairperson T.H. Ho, Singapore
10:20-10:50 Relevance of sentinel lymph nodes in Gyn-cancers, i.e. vulvar, cervical and endometrial cancers
G.K. Chew, Singapore
10:50-11:20 Advances in minimally invasive and robotic surgery for gynecological cancers
T. Lim, Singapore
11:20-11:50 Updates in chemotherapy for ovarian cancer: Neoadjuvant chemotherapy vs. upfront surgery for advanced ovarian cancer
H.T. See, Singapore
Objectives: Upon completion of this debate, the audience will have learned:
  • The importance of the sentinel node, robotic surgery and neoadjuvant in the diagnosis and management of gynecological oncology
  • Is robotic surgery real progress?

11:50-12:10 Poster viewing

12:10-13:40
THE PLACE OF BIOMARKERS AND IMAGING IN THE MANAGEMENT OF OVARIAN CANCER
Capsule
No agreement exists as to the most effective way in which to follow-up patients with epithelial ovarian cancer
ChairpersonL. Wong, Singapore
12:10-12:40 Should biomarkers be used routinely for the monitoring of epithelial ovarian cancer; the pros and cons?
H.L. Kong, Singapore
12:40-13:10 Imaging should be used for monitoring patients with epithelial ovarian cancer
J.W. Kwek, Singapore
13:10-13:40 Case Study presentation
L. Wong, Singapore
Objectives: Upon completion of this debate, the audience will learn:
  • The use of biomarkers for monitoring ovarian cancer patients
  • The use of imaging in monitoring ovarian cancer patients
  • Combined use of biomarkers and imaging for ovarian cancer monitoring

13:40-14:30 Lunch break

14:30-16:00
CERVICAL CANCER AND HUMAN PAPILLOMA VIRUS (HPV)
Capsule
Vaccination has the potential to save lives by preventing cervical cancer, while reducing the need for biopsies and invasive procedures associated with abnormal Pap Tests
Chairperson A.I. Cheran, Singapore
Discussants
W.J. Ledger, USA
S.K. Tay, Singapore
C.L. Lee, Taiwan
Discussion: Does vaccination mark the end of cervical cancer?
Questions to the panel:
  1. Is routine HPV DNA typing useful?
  2. Self-sampling in screening
  3. Time to achieve the promises of vaccination
  4. Screening vaccinated women
  5. Is there concern that migration to other types of HPV will become the main cause of HPV-related cervical cancer?
  6. Is the Pap smear obsolete in immunized patients?
  7. Routine inclusion of colposcopy in a pelvic examination? If so, how often?
  8. Vaccine safety
  9. Should men be vaccinated?

16:00-16:30 Coffee break

16:30-18:00
FREE COMMUNICATIONS - INFERTILITY & ART / GYNECOLOGY
Chairperson Z. Wiener–Megnazi, Israel
16:30-16:36 Synchronized blastomere cleavage at cryopreservation: effect on subsequent embryo survival, pregnancy and live birth rates.
Z. Wiener – Megnazi, Israel
16:36-16:42 Biological efficiency of natural cycle IVF is higher than controlled ovarian stimulation IVF
M. Nitzscke, Germany
16:42-16:48 Investigation of the outcomes of in vitro fertilization in comparison to intra cytoplasmic sperm injection using in vitro matured human oocytes
M. Walls, Australia
16:48-16:54 Individualization of luteal support in IVF cycles improves clinical pregnancy rates
S. Balasubramanyam, India
16:54-17:00 Slow freezing vs. vitrification of oocytes: A comprehensive meta-analysis
E. Vishwakarma, USA
17:00-17:06 Cumulus cells as a non-invasive biomarker of oocyte quality & ART outcomes?
Z. Huang, Singapore
17:06-17:12 Cessation of the oral contraceptive pill and changes in serum AMH concentration: A case study within an external quality assurance (EQA) scheme
E. Zuvela, Australia
17:12-17:18 Role of baseline antral follicle count and anti-mullerian hormone in the first ivf in predicting cumulative live birth
E. Ng, China
17:18-17:24 Hysterectomy for large uterine leiomyomas: Where is the scar?
R.N. Behera, India
17:24-17:30 Health belief model scale for cervical cancer and pap smear test: Psychometric testing
G. Guvenc, Turkey
17:30-17:36 Consanguinity and its association with sociodemographic variables in Pakistan
F. Khan, Pakistan
17:36-17:42 The influence of Danazol on angiogenesis and inflammatory response in endometriosis
M. Szubert, Poland
17:42-17:48 Determining the level of information of pregnant women about vaccines applied during pregnancy and their attitudes and behaviors towards vaccinations
A. Celikel, Turkey
17:48-17:54 Uterine artery embolization as a treatment and salvage procedure in obstetrical and Gynaecological emergencies
S. Puri, India